A humanized model of membrane attack complex (MAC) formation on murine retina and compositions, kits and methods for treatment of macular degeneration

Details for Australian Patent Application No. 2009215118 (hide)

Owner Tufts University

Inventors Cashman, Siobhan M.; Kumar-Singh, Rajendra; Ramo, Kasmir

Agent Pizzeys

Pub. Number AU-A-2009215118

PCT Pub. Number WO2009/102488

Priority 61/066,062 15.02.08 US; 61/066,288 19.02.08 US; 61/070,650 25.03.08 US

Filing date 13 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/70 (2006.01) - Carbohydrates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

19 August 2010 PCT application entered the National Phase

  PCT publication WO2009/102488 Priority application(s): WO2009/102488

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215128-Selective agonist of toll-like receptor 3

2009215111-Quinolizidinone M1 receptor positive allosteric modulators